Treatment of children from 6 to 11 years old affected by moderate-severe atopic dermatitis with dupilumab: a first perspective from a single-center real-life experience in Italy.

Colonna, C; Zussino, M; Monzani, N A; Ponziani, A; Cavalli, R

Colonna, C; Zussino, M; Monzani, N A; Ponziani, A; Cavalli, R.

Affiliation

Colonna C; Paediatric Dermatology Unit, Department of Clinical Sciences and Community Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Zussino M; Paediatric Dermatology Unit, Department of Clinical Sciences and Community Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Monzani NA; Neonatal Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Ponziani A; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
Cavalli R; Paediatric Dermatology Unit, Department of Clinical Sciences and Community Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

J Eur Acad Dermatol Venereol ; 36(6): e478-e480, 2022 06.

Article in En | MEDLINE | ID: mdl-35067995

Subject(s)

Dermatitis, Atopic; Antibodies, Monoclonal, Humanized/therapeutic use; Child; Dermatitis, Atopic/drug therapy; Humans; Italy; Severity of Illness Index; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Dermatitis, Atopic Limits: Child / Humans Country/Region as subject: Europa Language: En Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Dermatitis, Atopic Limits: Child / Humans Country/Region as subject: Europa Language: En Year: 2022 Type: Article